Carlos Andrés Pinto-Díaz
Datos Biográficos
| ID | 7505227 |
|---|---|
| NOMBRE | Carlos Andrés Pinto-Díaz |
| NOMBRES | Carlos Andrés |
| APELLIDO | Pinto-Díaz |
| FIRMA | PINTO-DÍAZ C A |
| AFILIACIONES | Organización Panamericana de la Salud, Washington D. C., Estados Unidos. |
| VERIFICADO | No |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2024 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2025 |
| ÍNDICE H | 0 |
Análisis del sistema de vigilancia de los Esavi por vacunas contra la Covid-19 en Colombia, 2021-2023
The AEFI surveillance indicators for COVID-19 were met. The regulations and functions of the health authorities provided a solid basis for vaccine pharmacovigilance activities, allowing effective use of technical resources. A regulatory framework for non-COVID-19 vaccines, continuous training, and greater automation is needed in order to improve the capacity of the vaccine safety program
Experiencias y desafíos de la Comisión nacional asesora de eventos supuestamente atribuibles a la vacunación o inmunización graves de Ecuador, 2020-2023
The National Advisory Commission has played an essential role in vaccine safety surveillance in Ecuador by ensuring reporting, causality analysis, and investigation of serious ESAVIs. Challenges were identified and will need to be addressed to maintain public trust in immunization programs
Sin obras prominentes en esta página.
Experiencias y desafíos de la Comisión nacional asesora de eventos supuestamente atribuibles a la vacunación o inmunización graves de Ecuador, 2020-2023
The National Advisory Commission has played an essential role in vaccine safety surveillance in Ecuador by ensuring reporting, causality analysis, and investigation of serious ESAVIs. Challenges were identified and will need to be addressed to maintain public trust in immunization programs
Análisis del sistema de vigilancia de los Esavi por vacunas contra la Covid-19 en Colombia, 2021-2023
The AEFI surveillance indicators for COVID-19 were met. The regulations and functions of the health authorities provided a solid basis for vaccine pharmacovigilance activities, allowing effective use of technical resources. A regulatory framework for non-COVID-19 vaccines, continuous training, and greater automation is needed in order to improve the capacity of the vaccine safety program
Humanities (2 obras) · Political science (2 obras) · Art (1 obras) · Communication and COVID-19 Impact (1 obras) · Coronavirus disease 2019 (COVID-19 (1 obras) · COVID-19 epidemiological studies (1 obras) · Medicine (1 obras) · Pharmacovigilance and Adverse Drug Reactions (1 obras) · Philosophy (1 obras) · Philosophy (1 obras)